Fibroscan

Visit our Gastroenterology Department for a complete list of services

FibroScan, a non-invasive device used to assess liver stiffness and steatosis (fatty liver), provides important information for diagnosing and monitoring liver diseases such as fibrosis, cirrhosis, and hepatitis. Here are the key features of FibroScan:

1. Liver Stiffness Measurement (LSM):
   • Uses transient elastography to measure liver stiffness, which correlates with the degree of fibrosis.
   • Provides a quick, painless, and reliable assessment of liver fibrosis.
2. Controlled Attenuation Parameter (CAP):
   • Measures the attenuation of ultrasound waves as they pass through the liver to quantify liver steatosis.
   • Provides a non-invasive means to assess and quantify fatty liver.
3. Non-Invasive and Painless:
   • Unlike liver biopsies, FibroScan is a non-invasive procedure that causes no pain or discomfort.
   • Can be performed in a clinical setting without the need for sedation or anesthesia.
4. Quick and Efficient:
   • The procedure typically takes about 5-10 minutes, providing immediate results.
   • Enhances patient throughput and convenience compared to more invasive diagnostic methods.
5. Portable and Easy to Use:
   • Compact and portable design allows for easy use in various clinical settings, including hospitals, clinics, and even mobile units.
   • User-friendly interface simplifies operation and data interpretation.
6. Reproducibility and Reliability:
   • High reproducibility and reliability of measurements, making it suitable for longitudinal monitoring of liver disease progression.
   • Standardized and validated against liver biopsy, ensuring clinical accuracy.
7. Wide Range of Applications:
   • Suitable for patients with chronic liver diseases such as hepatitis B and C, alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), and cirrhosis.
   • Provides valuable information for guiding treatment decisions and monitoring therapy response.
8. Real-Time Results:
   • Provides immediate feedback on liver health, allowing for timely clinical decision-making.
   • Eliminates the waiting period associated with traditional biopsy results.
9. Safe for All Patient Types:
   • Safe for use in a wide range of patients, including those with contraindications to liver biopsy.
   • Can be used in pregnant women, patients with coagulopathy, and those with advanced liver disease.
10. Cost-Effective:
    • Reduces the need for more invasive and expensive procedures like liver biopsies.
    • Provides a cost-effective solution for the routine assessment and monitoring of liver disease.
11. Clinical Guidelines and Endorsements:
    • Recognized and recommended by various clinical guidelines for the management of liver diseases.
    • Widely used and endorsed by hepatologists and gastroenterologists worldwide.
12. Multi-Frequency Probes:
    • Equipped with different probes (e.g., M and XL probes) to accommodate patients with varying body types and liver depths.
    • Ensures accurate measurements across a diverse patient population.
13. Digital Data Management:
    • Integrated software for data analysis, storage, and retrieval.
    • Allows for easy tracking of patient progress over time and facilitates clinical research.
14. Minimal Operator Dependency:
    • Designed to minimize operator dependency, ensuring consistent and accurate results regardless of who performs the test.
    • Reduces the variability seen with operator-dependent techniques like ultrasound elastography.

These features make FibroScan a valuable tool for the non-invasive assessment of liver health, offering a reliable and efficient alternative to traditional liver biopsy for diagnosing and monitoring liver diseases.